blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3430384

EP3430384 - AUTOMATED METHOD FOR ASSESSING CANCER RISK USING TISSUE SAMPLES, AND SYSTEM THEREFOR [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  08.05.2021
Database last updated on 30.03.2026
FormerRequest for examination was made
Status updated on  21.12.2018
FormerThe international publication has been made
Status updated on  22.09.2017
Most recent event   Tooltip28.03.2026New entry: Renewal fee paid 
Applicant(s)For all designated states
Proteocyte Diagnostics Inc.
MaRS Centre
South Tower
101 College Street
Suite 200
Toronto, Ontario M5G 1L7 / CA
[2019/04]
Inventor(s)01 / GU, Ying
c/o Proteocyte Diagnostics Inc.
MaRS Centre
South Tower
101 College Street, Suite 200
Toronto, Ontario M5G 1L7 / CA
02 / HWANG, Jason T.K.
c/o Proteocyte Diagnostics Inc.
MaRS Centre
South Tower
101 College Street, Suite 200
Toronto, Ontario M5G 1L7 / CA
03 / PRITZKER, Kenneth P.H.
c/o Proteocyte Diagnostics Inc.
MaRS Centre
South Tower
101 College Street, Suite 200
Toronto, Ontario M5G 1L7 / CA
04 / RALHAN, Ranju
c/o Proteocyte Diagnostics Inc.
MaRS Centre
South Tower
101 College Street, Suite 200
Toronto, Ontario M5G 1L7 / CA
05 / SHEN, Mi
c/o Proteocyte Diagnostics Inc.
MaRS Centre
South Tower
101 College Street, Suite 200
Toronto, Ontario M5G 1L7 / CA
 [2019/04]
Representative(s)Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Ganghoferstraße 68 B
80339 München / DE
[2019/04]
Application number, filing date17765612.114.03.2017
[2019/04]
WO2017CA50333
Priority number, dateUS201662308182P14.03.2016         Original published format: US 201662308182 P
[2019/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017156627
Date:21.09.2017
Language:EN
[2017/38]
Type: A1 Application with search report 
No.:EP3430384
Date:23.01.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 21.09.2017 takes the place of the publication of the European patent application.
[2019/04]
Search report(s)International search report - published on:CA21.09.2017
(Supplementary) European search report - dispatched on:EP02.07.2019
ClassificationIPC:G06T7/00, G06T7/62, G01N21/84, G01N15/02, G01N33/574
[2019/31]
CPC:
G01N33/5758 (EP); G06T7/0012 (EP); G06T7/62 (EP);
G01N2333/4727 (EP); G06T2207/10024 (EP); G06T2207/30024 (EP)
Former IPC [2019/04]G01N21/84, G01N15/02
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/04]
TitleGerman:AUTOMATISIERTES VERFAHREN ZUR BEURTEILUNG DES KREBSRISIKOS MITHILFE VON GEWEBEPROBEN UND SYSTEM DAFÜR[2019/04]
English:AUTOMATED METHOD FOR ASSESSING CANCER RISK USING TISSUE SAMPLES, AND SYSTEM THEREFOR[2019/04]
French:PROCÉDÉ AUTOMATISÉ POUR ÉVALUER UN RISQUE DE CANCER AU MOYEN D'ÉCHANTILLONS DE TISSU, ET SYSTÈME ASSOCIÉ[2019/04]
Entry into regional phase12.10.2018National basic fee paid 
12.10.2018Search fee paid 
12.10.2018Designation fee(s) paid 
12.10.2018Examination fee paid 
Examination proceduredeletedDate on which the examining division has become responsible
12.10.2018Examination requested  [2019/04]
28.01.2020Amendment by applicant (claims and/or description)
07.05.2021Despatch of a communication from the examining division (Time limit: M06)
15.11.2021Reply to a communication from the examining division
07.01.2025Despatch of a communication from the examining division (Time limit: M06)
23.07.2025Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
22.09.2025Reply to a communication from the examining division
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
22.09.2025Request for further processing filed
22.09.2025Full payment received (date of receipt of payment)
Request granted
26.09.2025Decision despatched
Fees paidRenewal fee
12.10.2018Renewal fee patent year 03
27.03.2020Renewal fee patent year 04
29.03.2021Renewal fee patent year 05
28.03.2022Renewal fee patent year 06
27.03.2023Renewal fee patent year 07
27.03.2024Renewal fee patent year 08
27.03.2025Renewal fee patent year 09
27.03.2026Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI] WO2007059629  (BC CANCER AGENCY et al.) [X] 1-5,9-12 * abstract; figure 1 * * paragraphs [0002] , [00 9] - [0014] - [0 37] - [0038] - [0 53] - [0056] *[I] 6-8
 [XI] CA2830501  (CERNOSTICS INC et al.) [X] 1-5,9-12 * abstract * * page 2, lines 29-31 * * page 3, lines 2-6 *[I] 6-8
 [XI] CA2904441  (METAMARK GENETICS INC et al.) [X] 1-5,9-12 * abstract * * page 2, line 28 - page 3, line 6 * * page 4, lines 11-13 * * page 3, lines 9-11 * * page 19 - page 20 *[I] 6-8
 [XI] US2006063190  (FISCHER TIMOTHY J et al.) [X] 1-5,9-12 * abstract * * paragraphs [0009] , [0 22] , [0 52] - [0055] - [0 62] , [0 87] , [0 88] *[I] 6-8
International search[X] CA2830501  (CERNOSTICS INC et al.) [X] 1 to 12 * . See abstract and pages 2-3 *
 [X] CA2904441  (METAMARK GENETICS INC et al.) [X] 1 to 12 * . See abstract and pages 2-4 and 19-20 *
 [X] US2006063190  (FISCHER TIMOTHY J et al.) [X] 1 to 12 * . See abstract, paragraphs [0009], [0022], [0052]-[0055], [0062], [0086] and [0087] *
 [A] WO2014204638  (BRIGHAM & WOMENS HOSPITAL et al.) [A] 1 to 12 * . See whole document *
 [A] CA2797585  (PRELUDE INC et al.) [A] 1 to 12 * . See whole document *
Examination  RALHAN R. ET AL: "Early Detection of Oral Lesions with Dysplasia at High-Risk of Cancer Development Using a Proteomic Signature Image Analysis Based StraticyteTM", GLOBAL ORAL CANCER FORUM 2016 (POSTER), 4 March 2016 (2016-03-04), XP055798963, Retrieved from the Internet [I] 6-8
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.